Orange Book product · Brand (NDA)
IVRA
MELPHALAN HYDROCHLORIDE
At a glance
Aug 18, 2023
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 18, 2023
2 yr 11 mo ago
Today
Patent 10537520 expires
Listed drug product patent expiration.
Jun 29, 2036
in 10 yr 2 mo
Pharmaceutical detail
Active ingredient
MELPHALAN HYDROCHLORIDE
Strength
EQ 90MG BASE/ML (EQ 90MG BASE/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 217110
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023HEPZATOBrand (NDA)
NDA 201848 · DELCATH SYSTEMS INC
- 2016EVOMELABrand (NDA)
NDA 207155 · ACROTECH BIOPHARMA
- 1992ALKERANBrand (NDA)
NDA 020207 · APOTEX
- 2024MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 206523 · AVET LIFESCIENCES
- 2024MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 215024 · HETERO LABS
- 2021MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 212960 · MEITHEAL
- 2020MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 209197 · BPI LABS
- 2020MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 209323 · ACTAVIS LLC
- 2020MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 210947 · INGENUS PHARMS LLC
- 2019MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 211463 · ARTHUR GRP
- 2019MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 209826 · GLAND
- 2019MELPHALAN HYDROCHLORIDEGeneric (ANDA)
ANDA 204817 · ALMAJECT
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10537520 | Jun 29, 2036 | in 10 yr 2 mo | Product |

